AARDVARK THERAPEUTICS, INC. (AARD) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $0.00; Additional Paid in Capital, Common StockUSD $226.69M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $0.00.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $0.00; Additional Paid in Capital, Common StockUSD $224.48M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $14.00K.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $0.00; Additional Paid in Capital, Common StockUSD $222.47M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $81.00K.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $0.00; Additional Paid in Capital, Common StockUSD $220.62M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $82.00K.
AARDVARK THERAPEUTICS, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $0.00 | $226.69M | $0.00 | $-151.89M | $74.80M | 3 month · $1.95M 6 month · $3.95M |
| 2026-03-31 | $0.00 | $0.00 | $224.48M | $14.00K | $-137.51M | $86.99M | 3 month · $2.00M |
| 2025-12-31 | $0.00 | $0.00 | $222.47M | $81.00K | $-115.92M | $106.63M | 12 month · $3.95M |
| 2025-09-30 | $0.00 | $0.00 | $220.62M | $82.00K | $-98.32M | $122.38M | 3 month · $1.50M 9 month · $2.37M |
| 2025-06-30 | $0.00 | $0.00 | $218.93M | $-3.00K | $-82.00M | $136.93M | 3 month · $634.00K 6 month · $867.00K |
| 2025-03-31 | $0.00 | $0.00 | $218.28M | $44.00K | $-67.64M | $150.69M | 3 month · $233.00K |
| 2024-12-31 | $0.00 | $0.00 | $3.68M | $0.00 | $-58.33M | $-54.64M | 12 month · $439.00K |
| 2024-09-30 | (m) | (m) | (m) | (m) | (m) | $-46.17M | 3 month · $144.00K 9 month · $266.00K |
| 2024-06-30 | (m) | (m) | (m) | (m) | (m) | $-42.31M | 3 month · $53.00K 6 month · $121.00K |
| 2024-03-31 | (m) | (m) | (m) | (m) | (m) | $-36.91M | 3 month · $67.00K |
| 2023-12-31 | (m) | (m) | (m) | (m) | (m) | $-34.80M | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |